These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32547950)

  • 1. RNA Sequencing Revealed Signals of Evolution From Gallbladder Stone to Gallbladder Carcinoma.
    Wang J; Xu C; Cheng Q; Zhao J; Wu S; Li W; Ma W; Liu C; Jiang X
    Front Oncol; 2020; 10():823. PubMed ID: 32547950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Long Noncoding RNAs Expression Profiles Between Gallstone and Gallbladder Cancer Using Next-Generation Sequencing Analysis.
    Wang Q; Bi P; Luo D; Cao P; Chen W; Yang B
    Int J Gen Med; 2024; 17():2417-2431. PubMed ID: 38813241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
    Singh TD; Gupta S; Shrivastav BR; Tiwari PK
    Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling of the comparative Transcriptomic Profile of Gallbladder Cancer using mRNA sequencing.
    Dixit R; Pandey M; Rajput M; Shukla VK
    Mol Biol Rep; 2022 Jul; 49(7):6395-6403. PubMed ID: 35469389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.
    Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P
    Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer.
    Srivastava A; Pandey SN; Dixit M; Choudhuri G; Mittal B
    J Gastroenterol Hepatol; 2008 Jun; 23(6):970-5. PubMed ID: 17944886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation.
    Yang S; Qin L; Wu P; Liu Y; Zhang Y; Mao B; Yan Y; Yan S; Tan F; Yue X; Liu H; Xue H
    PLoS One; 2023; 18(3):e0283770. PubMed ID: 36996251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of subtelomeric methylation and telomere length in gallstone disease and gallbladder cancer patients of North Central India.
    Poojary SS; Mishra G; Gupta S; Shrivastav BR; Tiwari PK
    J Hepatobiliary Pancreat Sci; 2016 May; 23(5):276-82. PubMed ID: 26856965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.
    Brägelmann J; Barahona Ponce C; Marcelain K; Roessler S; Goeppert B; Gallegos I; Colombo A; Sanhueza V; Morales E; Rivera MT; de Toro G; Ortega A; Müller B; Gabler F; Scherer D; Waldenberger M; Reischl E; Boekstegers F; Garate-Calderon V; Umu SU; Rounge TB; Popanda O; Lorenzo Bermejo J
    Hepatology; 2021 Jun; 73(6):2293-2310. PubMed ID: 33020926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining of RNA Methylation-Related Genes and Elucidation of Their Molecular Biology in Gallbladder Carcinoma.
    Yang C; Chen J; Yu Z; Luo J; Li X; Zhou B; Jiang N
    Front Oncol; 2021; 11():621806. PubMed ID: 33718182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallstones and gallbladder cancer-volume and weight of gallstones are associated with gallbladder cancer: a case-control study.
    Roa I; Ibacache G; Roa J; Araya J; de Aretxabala X; Muñoz S
    J Surg Oncol; 2006 Jun; 93(8):624-8. PubMed ID: 16724353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor analysis and construction of prediction models of gallbladder carcinoma in patients with gallstones.
    Zhu Z; Luo K; Zhang B; Wang G; Guo K; Huang P; Liu Q
    Front Oncol; 2023; 13():1037194. PubMed ID: 36923422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
    Buchegger K; Silva R; López J; Ili C; Araya JC; Leal P; Brebi P; Riquelme I; Roa JC
    Pathol Res Pract; 2017 May; 213(5):476-482. PubMed ID: 28285962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma.
    Gu X; Li B; Jiang M; Fang M; Ji J; Wang A; Wang M; Jiang X; Gao C
    Oncotarget; 2015 Aug; 6(24):20661-71. PubMed ID: 25970782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profile of cholecystokinin type-A receptor in gallbladder cancer and gallstone disease.
    Rai R; Tewari M; Kumar M; Singh TB; Shukla HS
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):408-14. PubMed ID: 21813391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer.
    Jain K; Mohapatra T; Das P; Misra MC; Gupta SD; Ghosh M; Kabra M; Bansal VK; Kumar S; Sreenivas V; Garg PK
    Ann Surg; 2014 Dec; 260(6):1073-80. PubMed ID: 24827397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
    Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
    Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
    J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
    Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
    Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.